MarketCapTrends
ANAB

AnaptysBio Inc. (ANAB)

NASDAQ · Healthcare

AnaptysBio Inc. annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • AnaptysBio Inc. shareholder equity for the quarter ending December 31, 2025 were 37.2M, a 47.49% decrease year-over-year.
  • AnaptysBio Inc. shareholder equity for 2025 were 37.2M, a 47.49% decrease from 2024.
  • AnaptysBio Inc. shareholder equity for 2024 were 70.9M, a 19.56% decrease from 2023.
  • AnaptysBio Inc. shareholder equity for 2023 were 88.1M, a 66.39% decrease from 2022.
  • AnaptysBio Inc. shareholder equity for 2022 were 262.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
AnaptysBio Inc. Annual Shareholder Equity (Millions of US $)
2025$37
2024$71
2023$88
2022$262
2021$356
2020$397
2019$405
2018$486
2017$308
2016$-38
AnaptysBio Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$37
2024-12-31$71
2023-12-31$88
2022-12-31$262
2021-12-31$356
2020-12-31$397
2019-12-31$405
2018-12-31$486
2017-12-31$308
2016-12-31$-38

AnaptysBio Inc. Shareholder Equity — FAQ

AnaptysBio Inc. (ANAB) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ANAB's shareholder equity history?

The chart and table above show AnaptysBio Inc.'s shareholder equity by year and by quarter, including the growth rate.